Share on StockTwits

Roka Bioscience (NASDAQ: ROKA) received a number of price target changes and ratings updates during the last week:

  • Roka Bioscience is now covered by analysts at Wedbush. They set an “outperform” rating and a $15.00 price target on the stock.
  • Roka Bioscience is now covered by analysts at Bank of America. They set a “buy” rating on the stock.
  • Roka Bioscience is now covered by analysts at Leerink Swann. They set an “outperform” rating and a $13.00 price target on the stock.
  • Roka Bioscience is now covered by analysts at Cowen and Company. They set an “outperform” rating and a $13.00 price target on the stock.

Shares of Roka Bioscience Inc (NASDAQ:ROKA) traded up 0.83% during mid-day trading on Wednesday, hitting $12.19. The stock had a trading volume of 23,702 shares. Roka Bioscience Inc has a one year low of $9.15 and a one year high of $13.00. The stock has a 50-day moving average of $11.00 and a 200-day moving average of $11.00. The company’s market cap is $214.9 million.

Roka Bioscience (NASDAQ:ROKA) last issued its quarterly earnings data on Monday, August 11th. The company reported ($11.28) earnings per share (EPS) for the quarter. The company had revenue of $1.40 million for the quarter. Analysts expect that Roka Bioscience Inc will post $-1.99 EPS for the current fiscal year.

Roka Bioscience, Inc is a molecular diagnostics company. The Company focuses on advanced testing solutions for the detection of foodborne pathogens.

Receive News & Ratings for Roka Bioscience Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roka Bioscience Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.